REL-ETHYL (2R,3S,4S)-4-(1,3-BENZODIOXOL-5-YL)-2-(4-METHOXYPHENYL)-3-PYRROLIDINECARBOXYLATE
UNII ZBE62CNX6Y
Substance Identification & Data
This profile provides standardized clinical and technical data for Rel-ethyl (2r,3s,4s)-4-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZBE62CNX6Y.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 173937-93-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H23NO5 SUCOGDSEXBRYSF-UXPWSPDFSA-N;SUCOGDSEXBRYSF-PWIZWCRZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Rel-ethyl (2r,3s,4s)-4-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.